ArticleThe Journal of experimental medicine2010

Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis.

Sara I Cunha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.